Cita APA

Pértega-Gomes, N., Vizcaíno, J. R., Miranda-Gonçalves, V., Pinheiro, C., Silva, J., Pereira, H., . . . Baltazar, F. (2011). Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BioMed Central.

Chicago Style Citation

Pértega-Gomes, Nelma, et al. Monocarboxylate Transporter 4 (MCT4) and CD147 Overexpression Is Associated With Poor Prognosis in Prostate Cancer. BioMed Central, 2011.

Cita MLA

Pértega-Gomes, Nelma, et al. Monocarboxylate Transporter 4 (MCT4) and CD147 Overexpression Is Associated With Poor Prognosis in Prostate Cancer. BioMed Central, 2011.